Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 281

Results For "NDA"

3746 News Found

LivaNova initiates targeted commercial launch of Essenz patient monitor
Biotech | April 10, 2022

LivaNova initiates targeted commercial launch of Essenz patient monitor

An intuitive monitor featuring a patient-tailored approach is now in clinical use in select centres in U.S. and Europe


Ministry of Ayush to organise two-day convention on World Homeopathy day
News | April 09, 2022

Ministry of Ayush to organise two-day convention on World Homeopathy day

World Homoeopathy Day is observed to commemorate the birth anniversary of the founder of Homoeopathy, Dr. Christian Fredrich Samuel Hahnemann to mark his 267th birth anniversary


Henlius' Serplulimab granted Orphan-Drug Designation for Small Cell Lung Cancer
Biotech | April 08, 2022

Henlius' Serplulimab granted Orphan-Drug Designation for Small Cell Lung Cancer

The company plans to file its NDA in China and MAA in the EU in 2022, making Hansizhuang potentially to be the world's first PD-1 inhibitor for the first-line treatment of SCLC


Knowledge Centre for Pharmaceutical Continuous Manufacturing
Biotech | April 08, 2022

Knowledge Centre for Pharmaceutical Continuous Manufacturing

Although PCM has advanced substantially in recent years, most of the valuable technical information resides with private companies and academic publications across multiple platforms


Essent Biologics launches Wharton's jelly-derived human mesenchymal stromal cells
Biotech | April 08, 2022

Essent Biologics launches Wharton's jelly-derived human mesenchymal stromal cells

Essent continues to broaden its highly characterized, low passage primary cell catalog


Pancreatic cancer lab-grown human organoids may predict effective chemotherapy treatment
Biotech | April 08, 2022

Pancreatic cancer lab-grown human organoids may predict effective chemotherapy treatment

Dr. Matthew Weiss presents data on patient organoids & cancer care at the American Surgical Association annual meeting


IAVI and Moderna partner to tackle broad global health priorities
Biotech | April 08, 2022

IAVI and Moderna partner to tackle broad global health priorities

Collaboration to target bacterial and viral pathogens including HIV, SARS-CoV-2, antimicrobial-resistant pathogens, and tuberculosis


CDSCO approves Phase II/III trial of Akston Bio’s Covid vaccine candidate in India
Biotech | April 08, 2022

CDSCO approves Phase II/III trial of Akston Bio’s Covid vaccine candidate in India

Veeda Clinical Research will submit data in an application for Emergency Use Authorisation


Proof Diagnostics seeks EUA for CRISPR-based molecular point-of-care Covid-19 test
Biotech | April 08, 2022

Proof Diagnostics seeks EUA for CRISPR-based molecular point-of-care Covid-19 test

If authorized by the USFDA, the Proof Lab Test System may be used to deliver accurate, actionable, lab-quality results for Covid-19 in as little as 18 minutes


Precaution dose for over 18 from April 10 at private vaccination centres
News | April 08, 2022

Precaution dose for over 18 from April 10 at private vaccination centres

About 96% of all 15+ population in the country have received at least one Covid-19 vaccine dose while about 83% of 15+ population has received both the doses